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A B S T R A C T
Desmostachya bipinnata (L.) Stapf, Poaceae, or Kusha in Sanskrit, is a sacred grass used 
extensively in Indian Vedic practices. It is well known for its medicinal value and is used 
in traditional Indian medicine to treat microbial infection in combination with other 
herbs. An effort has been made to isolate and characterize the bioactive compounds from 
the hydroalcoholic extract of D. bipinnata through bioassay guided fractionation, column 
chromatography.  Their individual or combined antimicrobial properties were determined 
by the Resazurin Microtitre Assay, the checkerboard assay in combination with antibiotics, 
and by time kill curve analysis. E-Sitosterol-D-glucopyranoside was the bioactive compound 
identified to have the best antimicrobial activity (MIC 6-50 μg/ml) and it works synergistically 
with most antibiotics, especially with ciprofloxacin. Time kill curves showed that BS kills 
most of the pathogens within 5-10 h. To our knowledge at its best, this is the first time report 
of antibacterial synergy of E-sitosterol-D-glucopyranoside from D. bipinnata.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Introduction
Desmostachya bipinnata (L.) Stapf, Poaceae, is considered a highly 
sacred grass among Vedic scholars in India. It is known as 
‘Kusha’ in Sanskrit. It constitutes a vital ingredient for almost 
all Vedic rituals and sacrifices. Its miraculous healing powers 
and medicinal value have been well documented in various 
Ayurvedic texts and preparations such as Tripanchamool, 
Kusablecha, and Kusadya-ghrita (Shrestha et al., 2000). Its 
medicinal main activities are as astringent, galactagogue, 
analgesic, antipyretic, aphrodisiac, anti-inflammatory, wound-
healing, anti-asthmatic, anti-diuretic and as a sedative to 
pregnant uterus. It is used along with other herbs to treat 
dysentery, diarrhea, jaundice, dysuria, nausea, menorrhagia 
and skin infections (Kirtikar and Basu, 1918; Joshi, 2003; 
Alikhan and Khanun, 2004).
The scarcity of fresh and novel therapeutic agents 
compound the severe, relentless global clinical problem: 
antibiotics ‘resistance’, and has also put on the spotlight, 
the generous use of already commercialized antibiotics 
(Boucher et al., 2009). This scenario thus signals a critical 
need for innovation, which is further exacerbated due to 
a global retreat on the development of new API (Active 
Pharmaceutical Ingredient) by the pharmacological sector. 
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Combinations of various small bioactive molecules having 
particular individual or multiple targets have been suggested 
as potential antimicrobial agents, (Sharom et al., 2004; Lehar 
et al., 2007) evidenced by the effects observed in microbial 
models at various levels of gene expression, genetic 
communication and at the protein interface (Parsons 
et al., 2004; Costanzo et al., 2010). Molecule combinations are 
thus proposed to thwart micoorganism resistance (Walsh, 
2000). The repurpose of traditional drugs combined with 
new ones thus could lessen the costs for the development 
of new pharmaceutical leads into simple but modern day 
resistant diseases. It is also critically imperative that new 
drugs be evaluated along with other traditional drugs, for 
the interactions among them. Thus, the current trend in 
development of novel therapeutics lies in the exploration of 
them as combinations with other reputed drugs. We have 
attempted to track this trend with our bioactive molecule 
E-sitosterol-D-glucopyranoside (BS) isolated for the first time 
from D. bipinnata.
Our present study focuses on the bioassay guided isolation 
of E-sitosterol-D-glucopyranoside from leaves of D. bipinnata 
for the first time, and its ability to kill common bacterial 
pathogens. Emphasis has also been laid in finding out the 
actual time taken for antimicrobial action by BS on pathogens 
through time kill analysis. 
Materials and methods
Collection of plant material and extraction
Leaves of Desmostachya bipinnata  (L.) Stapf, Poaceae, 
were obtained along the riverbeds of River Cauvery 
in and around Thanjavur, India. The samples were 
authenticated by Dr. Jayendran from the Department of 
Botany of Government Arts College, Ootacamund, India. 
A voucher specimen (JDB1422), after matching with 
authenticated herbarium sample RHT22739 (RAPINAT 
Herbarium, Trichy, India), was deposited in Government 
Arts College, Ootacamund, India. The leaves were shade 
dried and ground to a fine powder and used for extraction. 
Extracts were prepared by soaking 1 kg of plant material 
in n-hexane, ethyl acetate and 70% aqueous methanol 
successively at room temperature for 24 h and repeated 
thrice with the residue. The extract was filtered through 
Whatman nº1 filter paper, and then all the filtrates were 
pooled up successively and concentrated under vaccum 
by rotary evaporator (Buchi® Rotavap R-210).
Chemicals and instrumentation
All reagents were purchased from Sigma-Aldrich. TLC was 
monitored with silica gel-precoated aluminum sheets (Type 
60 F254, Merck, Darmstadt, Germany) and the spots were 
visualized in the ultraviolet light chamber, Iodine chamber, 
5% MeOH-H2SO4 mixture. Elemental analyses were carried out 
on an automatic Flash EA 1112 Series, CHN Analyzer (Thermo). 
All melting points were measured using Buchi-545.1H NMR 
and 13C NMR spectra were determined on a Bruker-400 NMR 
spectrometer and chemical shifts were expressed as part per 
million against TMS as internal reference. Mass spectra were 
recorded on Agilent 1200 (Liquid Chromatography), Agilent 
6320 (Quadrupole Mass Analyzer) spectrophotometer.
Bio-assay guided fractionation and compound isolation
The D. bipinnata extracts were subjected to antimicrobial 
assay and the hydroalcoholic extract showed the highest 
antimicrobial activity. Subsequently, hydroalcoholic extract 
(30 g) was taken for column chromatography using silica 
gel (60-120 mesh) (150 g) packed in a glass column of 4 × 
45 cm with bed height of 30 cm. Elution was started with 
n-hexane, followed by increasing ethyl acetate (EA)-n-
hexane combinations (5, 10, 20, 40 and 80% EA in n-hexane) 
and finally with EA followed by MeOH. The column 
elution was monitored by TLC and fractions were pooled 
based on similar TLC profiles. In total, seven fractions 
were collected and concentrated under reduced pressure 
in a rotary evaporator. Each fraction was determined 
for its antibacterial efficacy against various pathogens 
with Ciprofloxacin as control antibiotic. Fraction 6 (MF6) 
(3.5 g) and 7 (MF7) (3.1 g) were found to be most active which 
were then combined together and subjected to column 
chromatography with silica gel (100-200 mesh) and eluted 
with chloroform, chloroform-methanol (2, 4, 8, 10 and 20 
%) and methanol successively. Two fractions that eluted 
at 4% methanol-chloroform were pooled together and 












Pathogens and antibiotics used
Staphylococcus aureus (MTCC 96, 3160), Bacillus subtilis 
(MTCC 441), Enterococcus faecalis (MTCC 439), Escherichia coli 
(MTCC 723), Vibrio cholera (MTCC 3904), Klebsiella pneumonia 
(MTCC 432), Proteus vulgaris (MTCC 426), Proteus mirabilis 
(MTCC 425), Shigella dysenteriae (ATCC 23513), Pseudomonas 
aeruginosa (MTCC 741, 1688) were used for the antimicrobial 
studies. Commercial antibiotics were purchased from 
Sigma-aldrich India which included Amoxicillin (AMX), 
Ampicillin (AMP), Methicillin (MET), Ciprofloxacin (CIP), 
Gentamicin (GEN), Chloramphenicol (CHL), Azithromycin 
(AZM), Erythromycin (ERY), Tetracycline (TET), Polymyxin 
B (PMB). All pathogens were maintained on nutrient agar 
slant cultures at 4°C. 
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Inoculum preparation
All determination procedures of antimicrobial activity were 
done and inoculum size was standardized according to 
the National Committee for Clinical Laboratory Standards 
guidelines (NCCLS, 1993). Mueller Hinton Broth (MHB; HiMedia, 
Mumbai, India) was used to prepare inoculum and grown 
in incubator orbital shaker at 37°C for 4-8 h until cultures 
attained turbidity of 0.5 McFarland Unit. Inoculum size was 
adjusted and standardized to 5 × 105 CFU ml-1 throughout the 
experiments.
Determination of antibacterial efficacy
The minimum inhibitory concentrations (MIC) were 
determined for all D. bipinnata leaves extracts, fractions of 
column chromatography and isolated bioactive compound 
by broth dilution method. However, tests for purified isolated 
compounds were carried out in triplicate using modified 
Resazurin Microtitre Assay (REMA) (Martin et al., 2003). Stock 
solutions of samples at 500 μg/ml were prepared by dissolving 
the samples in 10% dimethyl sulphoxide (DMSO). The test 
samples were diluted in MH broth. The concentration range 
was 3.9-500 μg/ml. In 96-well microtiter plates, 100 μl of each 
of the compound dilutions was added to a mixture of 90 μl 
of MHB and 10 μl of bacterial inoculum. The negative control 
consisted of 100 μl of 10% DMSO, 90 μL of MHB and 10 μl of cell 
suspension; the positive control had ciprofloxacin added (3.9-
500 μg/ml). Upon the incubation of the test plates at 30°C for 
24 h, cell viability was determined by adding 15 μl of a 0.01% 
(w/v) Resazurin solution to each of the wells, following an 
extra incubation period of 2 h at 30°C. Viable microorganisms 
reduced the blue dye to a pink color, which was detected 
by fluorescence scanning using a microfluorimeter (FLX-
800 fluorimeter, BioTek, Winooski, VT) set to an excitation/
emission profile of 530 nm/590 nm.
The MIC plates after incubation were taken for 
determination of minimum bactericidal concentrations (MBC) 
which is the lowest concentration of agent that kills 99.9% of 
the test bacteria. This was done by plating out aliquots onto 
each appropriate agar plate. Ciprofloxacin was used as control.
Combination studies
To study the interaction of isolated bioactive compound 
with other antimicrobial agents, combinations of the 
compound with commercial antibiotics were assessed by the 
checkerboard test (Cha et al., 2007). Pure compound combined 
with antibiotics at concentrations ranging from 1/32 × MIC to 
4 × MIC were prepared in MHB with standard inoculum size of 
5 × 105 CFU ml-1. Minimum bactericidal concentrations (MBC) 
were also found for the combinations prepared. The fractional 
inhibitory concentration index (FICI) was found as the sum of 
the FIC of each of the drugs. FIC is defined as the MIC of each 
drug used in combination, divided by the MIC of the drug when 
used alone. The interaction was defined as synergistic if the 
FIC index was less than or equal to 0.5; additive if the FIC index 
was greater than 0.5 and less than or equal 1.0; indifferent if 
the FIC index was greater than 1.0 and less than or equal to 
2.0, and antagonistic if the FIC index was greater than 2.0. All 
experiments were done in triplicates and data represented as 
arithmetic average.
Time kill curves
To assess the rate of growth inhibition of isolated bioactive 
compound against pathogens, bactericidal action was 
evaluated using time kill curves. Tubes containing isolated 
compound at MIC were inoculated with a suspension of 
pathogens yielding the final bacterial concentration in broth 
at 4.5-5.5 ×105 CFU. The tubes were thereafter incubated at 
37°C and viable counts were performed at 0, 0.5, 1, 2, 3, 4, 5, 
6, 12, 16, 20 and 24 h after compound addition. Aliquots of 
culture broth were taken, serially diluted and spread over agar 
plates and incubated for up to 48 h at 37°C. Repeated washing 
and centrifugation was done to minimize antibiotic carry over. 
Colony counts were done in triplicate and data represented as 
arithmetic mean.
Results
The compound (BS) was isolated as a white crystalline solid (1) 
and it responded positively to the Liebermann-Buchard test for 
steroids. On the basis of the spectral data, compound structure 
was elucidated as stigmast-5-en-3-O-E-D-glucopyranoside 
(E-sitosterol pyranoside). All the spectral data were in complete 
concurrence with the literature (Kojima et al., 1990).
A bio assay guided fractionation of the hydroalcoholic 
extract was performed and seven fractions (MF1- MF7) were 
obtained (Fig. 1). Fractions MF1 and MF2 were inactiv e against 
all tested strains. Other fractions- MF3, MF4 and MF5 did not 
exhibit considerable activity against all pathogens (Table 1). 
Fractions MF6 and MF7 exhibited significant activity against all 
the pathogens, and hence they were taken for further studies. 
The phytochemical analysis of MF6 and MF7 led to the isolation 
of the bioactive compound (E-sitosterol-D-glucopyranoside). BS 
exhibited acceptable activity against most of the pathogens, 
and particularly against E. faecalis, S. dysenteriae, and P. 
aeruginosa with MIC values of 15, 12 and 10 μg/ml respectively 
(NCCLS, 2007). The MIC determined was relatively high for S. 
aureus (MTCC 3160) (50 μg/ml) and moderate against the other 
S. aureus strain (MTCC 96). The MIC for BS against P. mirabilis 
and K. pneumonia (24, 25 and 25 μg/ml respectively) were also, 
relatively moderate. The MBC values for BS were gratifying and 
were on par with the tested antibiotics (Tables 1and 2). 
A vital observation grasped was that, BS worked 
synergistically in many cases, especially with ciprofloxacin, 
against most of the pathogens (FICI < 0.5) and additively 
against the rest of the pathogens (FICI 0.5 - 1.0). In addition, 
BS + polymyxin B combination evidenced synergistic activity 
against E. coli (FICI - 0.72), V. cholera (FICI - 0.5), K. pneumonia 
(FICI-0.5), and P. aeruginosa (FICI-0.5 & 0.35). Chloramphenicol 
blended well with BS to yield synergy against E. faecalis (FICI-
0.46), E. coli (FICI - 0.5), K. pneumonia (FICI-0.41), P. mirabilis 
(FICI-0.5), and P. aeruginosa (FICI - 0.5). Additive combinations 
of BS were also found to be plenty (especially with amoxicillin, 
methicillin; against most of pathogens), when compared to 
non-interactive and antagonistic combinations (Table 2). The 
rate of bacterial growth killing by BS, assessed by time-kill 
curves, showed that most of the pathogens die within 5-10 h 
from addition of BS in culture broth. However, much time was 
needed (20 h) for BS to kill Gram-positive S. aureus (MTCC 3160), 
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Figure 1 - Isolation of bioactive compound through bioassay 
guided fractionation.
†Antimicrobial active fraction/compound; *Hydroalcoholic 
extract; # Methanol fraction; $ E-Sitosterol-D-glucopyranoside.
Pathogen Type
Antimicrobial Agents






400 NA NA 120 42 48 24/40
Staphylococcus 
aureus (MTCC 3160)
NA NA NA NA 100 88 50/75
Bacillus subtilis 
(MTCC 441)
200 120 NA 80 20 14 12.5/20
Enterococcus faecalis 
(MTCC 439)
400 120 NA 80 32 24 15/26




460 NA 80 NA 46 46 12.5/25
Vibrio cholera 
 (MTCC 3904)
250 NA 100 NA 24 14 6.2/15
Klebsiella pneumonia 
(MTCC 432)
320 NA NA NA 34 36 25/56
Proteus vulgaris 
 (MTCC 426)
NA NA NA NA 36 42 17/42
Proteus mirabilis  
(MTCC 425)
NA NA NA NA 48 52 25/50
Shigella dysenteriae 
(ATCC 23513)








NA NA NA NA 30 30 10/24
MIC of D. bipinnata hydro-methanolic extract (DBME), Methanol fraction 6 and 7 (MF6 & 7); and E-Sitosterol-D-glucopyranoside (BS). Other 
fractions not represented are considered not active against all of the pathogens. The experiment was done in triplicates and values represented 
are arithmetic average. NA, Not Active/ No inhibition found over that concentration of antibacterial agent.
Table 1
Minimum inhibitory concentration of different components of Desmostachya bipinnata. 
Figure 2 - Rate of action of E-sitosterol-D-glucopyranoside (BS) 
on various pathogens (Time kill curves). Bactericidal activity of 
E-sitosterol-D-glucopyranoside at MBC against (a) Gram positive 
bacteria, (b) Gram negative bacteria. Most of the pathogens are 
killed within 5-8 h for Gram positive except Staphylococcus aureus 
(MTCC 3160) which exhibits some kind of resistive patterns 
and takes longer duration to die. Gram negative organisms 
are mostly killed within 5-10 h except Klebsiella pneumonia and 
Proteus mirabilis showing resistive configurations followed by 
Proteus vulgaris slightly showing late death.
{
indicating the slightly resistive nature of the pathogen. Gram-
negative organisms like K. pneumonia and P. mirabilis portrayed 
resistive patterns (for 24 h, respectively). Time-kill curves of 
other bacteria showed considerable similarity in their kill-
curve patterns which apparently explains the similar action 
and time taken by BS to kill the tested pathogens (Fig. 2).
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Pathogen
Antimicrobial Agents (MIC/MBC) (μg/ml)
BSb AMXc AMP MET CIP GEN CHL AZM ERY
Staphylococcus 
aureus
Ia 24/40 26/48 45/60 5/8 8/16 4/8 22/52 16/30 5/8
C 10/18 18/28 4/4 6/12 6/8 12/18 18/32 5/8
F 0.78/0.83 1.12/1.16 0.96/0.96 1.0/1.0 1.72/1.2 1.0/0.79 1.84/1.86 1.2/1.2
R Ad N A A N A N N
Staphylococcus 
aureus
I 50/75 60/75 60/72 8/20 12/18 14/30 30/52 22/46 8/16
C 20/40 34/52 6/12 6/10 20/42 20/34 30/42 12/18
F 0.73/1.0 1.24/1.41 0.87/0.76 0.6/0.68 1.84/1.96 1.0/1.0 1.96/1.47 1.74/1.36
R A N A A N A N N
Bacillus subtilis
I 12.5/20 12/26 20/32 16/36 6/10 4/10 12/18 16/40 12/20
C 8/16 8/16 6/10 2/4 3/6 12/18 6/12 5/10
F 1.3/1.41 1.1/1.3 0.85/0.7 0.5/0.5 1.0/0.9 1.96/1.9 0.85/0.9 0.81/1.0
R N N A S A N A A
Enterococcus 
faecalis
I 15/26 18/30 18/32 24/34 6/12 20/42 6/12 14/22 18/30
C 12/20 10/22 8/12 2/4 14/30 2/4 10/18 10/24
F 1.46/1.43 1.2/1.53 0.86/0.81 0.46/0.48 10.63/1.86 00.46/0.4 1.38/1.51 1.22/1.72
R N N A S N S N N
Escherichia coli
I 12.5/25 12/24 16/30 12/20 6/10 6/12 6/10 12/20 12/18
C 4/8 12/20 10/18 2/4 2/4 2/4 4/8 10/16
F 0.65/0.65 1.71/1.46 1.63/1.62 0.5/0.5 0.5/0.49 0.5/0.5 0.65/0.72 1.63/1.52
R A N N S S S A N
Vibrio cholerae
I 6.2/15 15/30 8/14 24/32 4/10 3/8 4/8 20/38 40/62
C 4/10 6/10 10/20 1/3 1/2 2/3 8/18 10/22
F 0.91/0.8 1.71/1.38 2.0/1.95 0.41/0.5 0.5/0.38 0.82/0.6 1.69/1.67 1.86/1.82
R A N N S S A N N
Klebsiella 
pneumonia
I 25/56 40/72 24/46 20/40 12/24 6/12 6/14 8/16 12/24
C 12/20 8/16 10/18 4/6 3/6 2/4 2/4 12/26
F 0.78/0.63 0.65/0.63 0.9/0.77 0.5/0.36 0.62/0.61 0.41/0.36 0.33/0.32 1.48/1.55
R A A A S A S S N
Proteus vulgaris
I 17/42 25/38 40/72 30/52 16/36 12/20 12/18 12/26 40/78
C 12/22 18/30 16/24 6/14 4/6 4/6 6/12 12/20
F 1.19/1.1 1.5/1.13 1.47/1.03 0.73/0.72 0.5/0.44 0.5/0.48 0.85/0.75 1.0/0.73
R N N N A S S A A
Proteus 
mirabilis
I 25/50 32/48 36/66 30/42 14/30 10/22 18/32 16/32 46/78
C 14/24 28/50 25/46 8/18 6/16 14/22 20/36 32/60
F 1.0/0.98 1.9/1.76 1.83/2.0 0.89/0.96 0.84/1.0 1.34/1.13 2.0/1.85 1.98/1.97
R A N N A A N N N
Table 2
Combination effects of E-sitosterol-D-glucopyranoside with commercial antibiotics.
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Shigella 
dysenteriae
I 12/30 16/32 20/40 18/32 4/6 4/8 22/42 10/20 20/36
C 6/12 12/20 14/20 2/4 4/10 14/32 4/12 8/16
F 0.88/0.78 1.6/1.17 1.94/1.29 0.67/0.8 1.33/1.58 1.8/1.83 0.73/1.0 1.0/0.75
R A N N A N N A A
Pseudomonas 
aeruginosa
I 10/16 30/56 18/38 12/26 6/12 4/6 6/14 12/24 20/42
C 6/12 4/8 2/4 2/4 1/2 2/4 4/6 12/20
F 0.8/0.96 0.6/0.71 0.37/0.4 0.5/0.5 0.35/0.46 0.5/0.5 0.73/0.63 1.8/1.73
R A A S S S S A N
Pseudomonas 
aeruginosa
I 10/24 28/42 12/24 12/24 8/14 4/8 8/18 8/18 24/42
C 14/24 8/18 4/10 4/8 2/4 3/8 6/12 14/24
F 1.9/1.57 1.47/1.5 0.73/0.83 0.9/0.9 0.7/0.67 0.68/0.78 1.35/1.17 1.98/1.57
R N N A A A A N N
 AMP, Ampicillin; MET, Methicillin; CIP, Ciprofloxacin; GEN, Gentamycin; CHL, Chloramphenicol;  AZM, Azithromycin; ERY,  Erythromycin;  
TET, Tetracycline; PMB, Polymyxin-B. 
aI, Individual; C, Combination; F, Fractional inhibitory concentration index (FICI); R, Results. 
bBS, E-Sitosterol-D-glucopyranoside.  
cCommercial Antibiotics; AMX, Amoxicillin.  
dObservations: S, Synergistic; A, Additive; N, No Interaction; T, Antagonistic; FICI, < 0.5 (Synergy), 0.5 - 1.0 (Additive), 1.0 - 2.0 (No interaction), > 2.0 
(Antagonistic).
Pathogen
Antimicrobial Agents (MIC/MBC) (μg/ml)
BSb AMXc AMP MET CIP GEN CHL AZM ERY
Discussion
Desmostachya bipinnata (L.) Stapf, Poaceae, is noted for its 
medicinal properties against skin infections and digestive 
problems. In the present study, a glycosidic compound 
(E-sitosterol-D-glucopyranoside) was isolated and its 
antimicrobial synergism with other antibiotics against 
common pathogens is demonstrated for the first time, with 
further studies on time kill curve analysis. This sacred plant 
has always been used in combination with other medicines 
in preparations of Ayurvedic/Siddha indian system (Kirtikar 
and Basu, 1918; Joshi, 2003). Much research has not been 
done in this plant and very few constituents have been 
isolated and characterized. One such compound isolated in 
this study is E-sitosterol-D-glucopyranoside.E-Sitosterol-D-
glucopyranoside has been previously reported in Triticum 
aestivum (Rozenberg et al., 2003), and Vitis vinifera (Rivero-
Cruz et al., 2008). The antibacterial activity of E-sitosterol-
D-glucopyranoside has also been previously reported 
(Chattopadhyay et al., 2001), where fraction containing 
E-sitosterol-D-glucopyranoside, isolated from the leaf 
extracts of Alstonia macrophylla exhibited MIC at 1000-2000 
μg/ml against resistant bacteria and > 128 μg/ml against 
fungal organisms. 
The fact that D. bipinnata extracts increase the properties 
of other medicinal preparations (works synergistically) is well 
documented by traditional medics in India (Shrestha et al., 
2000), and our work further substantiates this fact. Our study 
proves significant synergy and additive effects of BS-antibiotic 
combinations against various pathogens. To gain better 
insight about rate of action of our isolated compound, Time 
kill analysis was performed, which could be generally used to 
determine rapidity and duration of antibacterial action against 
particular pathogens (Devi et al., 2010). Our studies show that, 
BS completely kills Gram-positive and Gram-negative bacteria 
within 5-10 h, except Staphylococcus aureus (MTCC 3160), Klebsiella 
pneumonia and Proteus mirabilis (Fig. 2). Further phytochemical 
pursuits for other similar glycosides or different bioactive 
molecules from this medicinally active plant will open up new 
prospects in this field of research. Also, combination of such 
anticipated molecules with other well established drugs could 
further solve the question of drug interactions and synergism 
as substantiated by traditional texts.
In conclusion, our study details the concepts concerned 
with the isolation of a bioactive compound called E-sitosterol-
D-glucopyranoside and its structural elucidation. Antibacterial 
activity of BS and combinations of bioactive compound with 
antibiotics yielded patterns of synergism and addition being 
few the observations of non-interaction and antagonism, all 
this conforming the unique result of this study. The duration 
Table 2 cont.
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of bactericidal action exhibited by BS was determined and it 
was inferred that 5-10 h timescale was required for BS to exhibit 
complete cidal activity on most of the pathogens.
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